Peter Nagy
Peter Nagy
Bethesda Children's Hospital
Geverifieerd e-mailadres voor bethesda.hu - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
V Roessner, KJ Plessen, A Rothenberger, AG Ludolph, R Rizzo, L Skov, ...
European child & adolescent psychiatry 20 (4), 173-196, 2011
4902011
Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders
PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ...
Cell 179 (7), 1469-1482. e11, 2019
3912019
European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions
C Verdellen, J Van De Griendt, A Hartmann, T Murphy
European child & adolescent psychiatry 20 (4), 197-207, 2011
3172011
European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment
DC Cath, T Hedderly, AG Ludolph, JS Stern, T Murphy, A Hartmann, ...
European child & adolescent psychiatry 20 (4), 155-171, 2011
2592011
European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation
KR Müller-Vahl, DC Cath, AE Cavanna, S Dehning, M Porta, ...
European child & adolescent psychiatry 20 (4), 209-217, 2011
1812011
Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate …
L Hennissen, MJ Bakker, T Banaschewski, S Carucci, D Coghill, ...
CNS drugs 31 (3), 199-215, 2017
1372017
Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette syndrome
AY Huang, D Yu, LK Davis, JH Sul, F Tsetsos, V Ramensky, I Zelaya, ...
Neuron 94 (6), 1101-1111. e7, 2017
1052017
Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families
I Karagiannidis, S Dehning, P Sandor, Z Tarnok, R Rizzo, T Wolanczyk, ...
Journal of medical genetics 50 (11), 760-764, 2013
962013
Interrogating the genetic determinants of Tourette’s syndrome and other tic disorders through genome-wide association studies
D Yu, JH Sul, F Tsetsos, MS Nawaz, AY Huang, I Zelaya, C Illmann, ...
American Journal of Psychiatry 176 (3), 217-227, 2019
892019
Association of risk of suicide attempts with methylphenidate treatment
KKC Man, D Coghill, EW Chan, WCY Lau, C Hollis, E Liddle, ...
JAMA psychiatry 74 (10), 1048-1055, 2017
722017
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase …
RW Dittmann, E Cardo, P Nagy, CS Anderson, R Bloomfield, B Caballero, ...
CNS drugs 27 (12), 1081-1092, 2013
702013
Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families
I Karagiannidis, R Rizzo, Z Tarnok, T Wolanczyk, J Hebebrand, ...
Molecular psychiatry 17 (7), 665-668, 2012
612012
De novo sequence and copy number variants are strongly associated with tourette disorder and implicate cell polarity in pathogenesis
S Wang, JD Mandell, Y Kumar, N Sun, MT Morris, J Arbelaez, C Nasello, ...
Cell reports 24 (13), 3441-3454. e12, 2018
562018
Emotion recognition pattern in adolescent boys with attention-deficit/hyperactivity disorder
N Aspan, C Bozsik, J Gadoros, P Nagy, J Inantsy-Pap, P Vida, J Halasz
BioMed research international 2014, 2014
562014
Genetic association signal near NTN4 in Tourette syndrome
P Paschou, D Yu, G Gerber, P Evans, F Tsetsos, LK Davis, I Karagiannidis, ...
Annals of neurology 76 (2), 310-315, 2014
512014
Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort
B Bertelsen, H Stefánsson, LR Jensen, L Melchior, NM Debes, C Groth, ...
Biological psychiatry 79 (5), 383-391, 2016
342016
European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents
A Schrag, D Martino, A Apter, J Ball, E Bartolini, N Benaroya-Milshtein, ...
European child & adolescent psychiatry 28 (1), 91-109, 2019
302019
Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: A phase IV, 2-year, open-label study in Europe
DR Coghill, T Banaschewski, P Nagy, IH Otero, C Soutullo, B Yan, ...
CNS drugs 31 (7), 625-638, 2017
302017
Randomized, double-blind, placebo-controlled acute comparator trials of lisdexamfetamine and extended-release methylphenidate in adolescents with attention-deficit …
JH Newcorn, P Nagy, AC Childress, G Frick, B Yan, S Pliszka
CNS drugs 31 (11), 999-1014, 2017
292017
Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention …
RW Dittmann, E Cardo, P Nagy, CS Anderson, B Adeyi, B Caballero, ...
CNS drugs 28 (11), 1059-1069, 2014
282014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20